Self-reported nonadherence with antiretroviral drugs predicts persistent condition

HIV Clinical Trials

Volumn 2, Issue 4, 2001, Pages 323-329

  Murri, R ^a   Ammassari, A ^a   De Luca, A ^a   Cingolani, A ^a   Marconi, P ^a   Wu, A W ^a   Antinori, A ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Adherence; Protease inhibitors; Self report

Indexed keywords

ANTIRETROVIRUS AGENT; INDINAVIR; PROTEINASE INHIBITOR; RITONAVIR;

ADULT; AGE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG BLOOD LEVEL; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ITALY; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PREDICTION; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; QUESTIONNAIRE; SELF REPORT; STATISTICAL ANALYSIS; TIME; VOMITING;

EID: 0034889226     PISSN: 15284336     EISSN: None     Source Type: Journal    
DOI: 10.1310/KDM0-RU5W-NVTW-N9MC     Document Type: Article

References (26)

1. Antiretroviral therapy in adults: Updated recommendations of the International AIDS Society-USA Panel
2. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection
3. Adherence and viral load in HIV-infected drug users: Comparison of self-report and medication event monitors (MEMS)
4. In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors
5. Patient compliance and drug failure in protease inhibitor monotherapy
6. L'aderenza ai farmaci antiretrovirali
7. Patient-reported nonadherence to HAART is related to protease inhibitor levels
8. A health status questionnaire using 30 items from the Medical Outcomes Study. Preliminary validation in persons with early HIV infection
9. An index of symptoms for infection with human immunodeficiency virus: Reliability and validity
10. Incidence of adverse reactions in HIV patients treated with protease inhibitors: A cohort study
11. Constitutional symptoms and health-related quality of life in patients with symptomatic HIV disease
12. Clinical predictors of functioning in persons with acquired immunodeficiency syndrome
13. Characterizing patterns of drug-taking behavior with a multiple drug regimen in an AIDS clinical trial
14. Adherence: A necessity for successful HIV combination therapy
15. The extent of non-adherence in a large AIDS clinical trial using plasma dideoxynucleoside concentrations as a marker
16. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy
17. Potential factors affecting adherence with HIV therapy
18. Predictors of adherence with triple combination antiretroviral therapy
19. Adherence to HAART in French HIV-infected injecting drug users: The contribution of buprenorphine drug maintenance treatment
20. Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients
21. Understanding adherence to HIV medication
22. Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued?
23. Sensitivity, specificity, reliability, and clinical validity of provider-reported symptoms. A comparison with self-reported symptoms
24. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response
25. Adherence and effectiveness of protease inhibitors in clinical practice
26. Patient adherence to highly active antiretroviral therapy for HIV-1 infection in a nation-wide cohort study in the Netherlands